Hot Stocks

The stock market changes from minute to minute, and what’s hot today may not be hot tomorrow. Our expert analysts spot hot stocks that are heating up before the crowd swoops in to bid prices higher, and our journalists sift through the noise to shine a light on trending investments -- in spaces ranging from quantum computing to marijuana stocks -- to determine whether they’re actually worth your time.

Intel: A Cheap Defensive Cash Flow Machine

Intel has had some notable slip-ups in recent years. However, the business is doing better than you think, and INTC stock is attractive here.

SunPower Is Turning Back to Homeowners

SunPower is buying Blue Raven, hoping the residential market will deliver profits for SPWR stock now that solar energy is the cheap power.

ChargePoint Stock Is Priced Wrong, and Will Correct Upwards

There's a ripe buying opportunity as CHPT stock lags while ChargePoint forges ahead with revenue growth and value-added acquisitions.

Moderna Stock Looks Fully Valued Here, But It Has a Great Future

Moderna has a host of vaccines in its pipeline, including against cancer and HIV. It's not a one-trick pony.

Fisker Stock Could Be a Long-Term Buy, But Wait Until You See the Ocean

Investors will have to wait another year before Fisker's first vehicle, the Ocean, goes into production. However, a sneak preview may give FSR stock a lift.

Meta Materials Stock Is a Speculative Play That Could Pay Off Big

Speculators are betting that Meta has promising nanocomposites that address multiple markets, realizing revenue in 1H/2022.

Debt, Rivals Leave SmileDirectClub Investors With Little to Smile About

Along with soaring competitive pressures and SmileDirectClub's fragile balance sheet, long-term prospects remain volatile for SDC stock.

Groundbreaking Tech Makes Bionano Genomics Look Better Than Ever

Off and on the price chart, Bionano Genomics could be the next big thing in genomics with multiple catalysts for BNGO stock.

Tellurian Has the Right Jockey, But it Still Has a Race to Run

Tellurian is a play on liquefied natural gas (LNG). The expansive experience of its founder makes TELL stock attractive.

MicroVision Stock May Not Be a ‘No,’ But It’s Clearly a ‘Not Yet’

MicroVision may have game-changing lidar technology for autonomous vehicles. But autonomous vehicles are years away. And those two truths have to be reconciled before you invest in MVIS stock. 

The Challenges for Zomedica Continue, But It Still Has Huge Potential

Cautious investors may want to hold off, as no matter what direction it goes (higher or lower), it'll do so in a big way. But if you can stomach the risk, and have patience to wait out its current troubles, ZOM stock may be an opportunity.

3 Top Stocks With Upsides Over 50%, According to Wall Street Analysts

When looking for top stocks, instead of traditional valuation measures, look at stocks trading well below their upside potential.

Production Progress May Enable Lucid Stock to Hold Steady

The early-stage EV company's recent developments may enable LCID stock to perform relatively well in the volatile market.

Palantir Technologies Is Worth Getting Into Now, Though Another Dip Is Possible

Palantir Technologies reported strong Q2 results in mid-August.. Yet PLTR stock has fallen below where it was trading. Time to buy?  

Lordstown Motors Is the Poster Child for Blank-Check Firms

While RIDE stock crumbled under the weight of its underlying business problems, it’s also worth reminding ourselves of SPAC risks.

Globalstar Stock Seeks Catalysts as Revenue Slows and Debt Poses Risks

Globalstar lacks fundamental reasons that could move GSAT stock higher, while the downside risk is more likely.

In a Cyber War, It May Help to Own CrowdStrike Stock

Analysts want you to buy the dip on Crowdstrike, a cloud-based endpoint security company that has CRWD stock selling at 36x revenue.

Post-Merger Greenidge Generation Is Suffering From Bad Timing

GREE stock merged with Support.com a few weeks ago. Crypto regulations and fundamental issues already sent the price lower by 50%.

The Rallies In Vinco Ventures Stock Are Always More Hype Than Substance

The financial metrics behind BBIG stock do not support the idea of an improving thesis. The current price action is more hype than substance.